The post RBA to hold cash rate at 3.60% through 2026 — Reuters poll appeared on BitcoinEthereumNews.com. The Reserve Bank of Australia (RBA) will hold its cash rate at 3.60% at its December next week and keep it steady through 2026, according to the latest Reuters poll. All 38 economists in the December 1-4 poll expected the Australian central bank to leave its Official Cash Rate (OCR) unchanged at the end of its two-day meeting on December 9. Survey marked a notable shift in the outlook, with the median now expects the interest rates to remain steady through 2026, compared with anticipation for cuts as recently as last month. In the November survey, over 60% predicted at least one further reduction by April-June, compared to less than one-third in the recent poll. Among economists  who had a rates forecast until the end of 2026, a strong majority 19 of 33 expect rates to stay unchanged at 3.60%, and 10 forecast at least one cut. The remaining four expected the RBA to hike at least once. Market reaction As of writing, the AUD/USD pair is up 0.01% on the day at 0.6615. RBA FAQs The Reserve Bank of Australia (RBA) sets interest rates and manages monetary policy for Australia. Decisions are made by a board of governors at 11 meetings a year and ad hoc emergency meetings as required. The RBA’s primary mandate is to maintain price stability, which means an inflation rate of 2-3%, but also “..to contribute to the stability of the currency, full employment, and the economic prosperity and welfare of the Australian people.” Its main tool for achieving this is by raising or lowering interest rates. Relatively high interest rates will strengthen the Australian Dollar (AUD) and vice versa. Other RBA tools include quantitative easing and tightening. While inflation had always traditionally been thought of as a negative factor for currencies since it lowers the value of… The post RBA to hold cash rate at 3.60% through 2026 — Reuters poll appeared on BitcoinEthereumNews.com. The Reserve Bank of Australia (RBA) will hold its cash rate at 3.60% at its December next week and keep it steady through 2026, according to the latest Reuters poll. All 38 economists in the December 1-4 poll expected the Australian central bank to leave its Official Cash Rate (OCR) unchanged at the end of its two-day meeting on December 9. Survey marked a notable shift in the outlook, with the median now expects the interest rates to remain steady through 2026, compared with anticipation for cuts as recently as last month. In the November survey, over 60% predicted at least one further reduction by April-June, compared to less than one-third in the recent poll. Among economists  who had a rates forecast until the end of 2026, a strong majority 19 of 33 expect rates to stay unchanged at 3.60%, and 10 forecast at least one cut. The remaining four expected the RBA to hike at least once. Market reaction As of writing, the AUD/USD pair is up 0.01% on the day at 0.6615. RBA FAQs The Reserve Bank of Australia (RBA) sets interest rates and manages monetary policy for Australia. Decisions are made by a board of governors at 11 meetings a year and ad hoc emergency meetings as required. The RBA’s primary mandate is to maintain price stability, which means an inflation rate of 2-3%, but also “..to contribute to the stability of the currency, full employment, and the economic prosperity and welfare of the Australian people.” Its main tool for achieving this is by raising or lowering interest rates. Relatively high interest rates will strengthen the Australian Dollar (AUD) and vice versa. Other RBA tools include quantitative easing and tightening. While inflation had always traditionally been thought of as a negative factor for currencies since it lowers the value of…

RBA to hold cash rate at 3.60% through 2026 — Reuters poll

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The Reserve Bank of Australia (RBA) will hold its cash rate at 3.60% at its December next week and keep it steady through 2026, according to the latest Reuters poll.

All 38 economists in the December 1-4 poll expected the Australian central bank to leave its Official Cash Rate (OCR) unchanged at the end of its two-day meeting on December 9.

Survey marked a notable shift in the outlook, with the median now expects the interest rates to remain steady through 2026, compared with anticipation for cuts as recently as last month.

In the November survey, over 60% predicted at least one further reduction by April-June, compared to less than one-third in the recent poll.

Among economists  who had a rates forecast until the end of 2026, a strong majority 19 of 33 expect rates to stay unchanged at 3.60%, and 10 forecast at least one cut. The remaining four expected the RBA to hike at least once.

Market reaction

As of writing, the AUD/USD pair is up 0.01% on the day at 0.6615.

RBA FAQs

The Reserve Bank of Australia (RBA) sets interest rates and manages monetary policy for Australia. Decisions are made by a board of governors at 11 meetings a year and ad hoc emergency meetings as required. The RBA’s primary mandate is to maintain price stability, which means an inflation rate of 2-3%, but also “..to contribute to the stability of the currency, full employment, and the economic prosperity and welfare of the Australian people.” Its main tool for achieving this is by raising or lowering interest rates. Relatively high interest rates will strengthen the Australian Dollar (AUD) and vice versa. Other RBA tools include quantitative easing and tightening.

While inflation had always traditionally been thought of as a negative factor for currencies since it lowers the value of money in general, the opposite has actually been the case in modern times with the relaxation of cross-border capital controls. Moderately higher inflation now tends to lead central banks to put up their interest rates, which in turn has the effect of attracting more capital inflows from global investors seeking a lucrative place to keep their money. This increases demand for the local currency, which in the case of Australia is the Aussie Dollar.

Macroeconomic data gauges the health of an economy and can have an impact on the value of its currency. Investors prefer to invest their capital in economies that are safe and growing rather than precarious and shrinking. Greater capital inflows increase the aggregate demand and value of the domestic currency. Classic indicators, such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can influence AUD. A strong economy may encourage the Reserve Bank of Australia to put up interest rates, also supporting AUD.

Quantitative Easing (QE) is a tool used in extreme situations when lowering interest rates is not enough to restore the flow of credit in the economy. QE is the process by which the Reserve Bank of Australia (RBA) prints Australian Dollars (AUD) for the purpose of buying assets – usually government or corporate bonds – from financial institutions, thereby providing them with much-needed liquidity. QE usually results in a weaker AUD.

Quantitative tightening (QT) is the reverse of QE. It is undertaken after QE when an economic recovery is underway and inflation starts rising. Whilst in QE the Reserve Bank of Australia (RBA) purchases government and corporate bonds from financial institutions to provide them with liquidity, in QT the RBA stops buying more assets, and stops reinvesting the principal maturing on the bonds it already holds. It would be positive (or bullish) for the Australian Dollar.

Source: https://www.fxstreet.com/news/rba-to-hold-cash-rate-at-360-through-2026-reuters-poll-202512050149

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09